| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2754997 | Clinical Lymphoma Myeloma and Leukemia | 2013 | 8 Pages |
Abstract
Both auto-HCT and allo-HCT are associated with durable remission and prolonged survival. All 3 strategies (auto-HCT, allo-HCT, CT) were found to be feasible in the relapsed APL setting and result in long-term disease control in selected patients. In this retrospective analysis, overall survival for patients who received HCT was not significantly better than patients who received CT only, but a trend toward better outcomes was seen in patients who underwent auto-HCT, although not statistically significant.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Naveen Pemmaraju, Maria Florencia Tanaka, Farhad Ravandi, Heather Lin, Veerabhadran Baladandayuthapani, Gabriela Rondon, Sergio A. Giralt, Julianne Chen, Sherry Pierce, Jorge Cortes, Hagop Kantarjian, Richard E. Champlin, Marcos De Lima,